 CHICAGO, July 12, 2021 PRNewswire -- Hillrom NYSE: HRC today announced that the Delaware Court of Chancery ordered Hillrom to proceed with its proposed acquisition of Bardy Diagnostics, Inc. BardyDx, denying Hillroms claim of a Material Adverse Event under the terms of the acquisition agreement executed by the companies on January 15, 2021. HillromThe company intends to appeal this ruling to the Supreme Court of Delaware. 